Enter assignee name

Trademarks = 1

Forward Citations = 4

Loading Chart...

8 inventors (with patents filed for the assignee):

Kallanthottathil G Rajeev (8 out of 193 patents)

Caroline Reiss (5 out of 5 patents)

Souvik Biswas (4 out of 4 patents)

4. Alexandra Chadwick (4 out of 4 patents)

5. Christopher Cheng (3 out of 3 patents)

6. Padma Malyala (2 out of 3 patents)

7. Lisa N Kasiewicz (2 out of 2 patents)

8. Ellen Rohde (2 out of 2 patents)

8 patents: Sort by Forward Citations

1. 12410122 - Lipid formulations for gene editing (2025-09-09),

2. 12274753 - Compositions and methods for targeted RNA delivery (2025-04-14),

3. 12264175 - Compositions and methods for capping RNAS (2025-04-01),

4. 12115230 - Base editing of ANGPTL3 and methods of using same for treatment of disease (2024-10-15),

5. 12029795 - Base editing of PCSK9 and methods of using same for treatment of disease (2024-07-09),

6. 12024484 - Lipid formulations for gene editing (2024-07-02),

7. 11801306 - Compositions and methods for targeted RNA delivery (2023-10-31),

8. 11207416 - Compositions and methods for targeted RNA delivery (2021-12-28),

Verve Therapeutics, Inc. is a biotechnology company focused on developing therapies to treat cardiovascular diseases. They are pioneering a unique approach to gene editing to lower cholesterol levels and reduce the risk of heart-related conditions. The company aims to revolutionize the treatment of cardiovascular diseases and improve patient outcomes through their innovative research and development efforts.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

8 Patents

#243 in Cambridge, MA

#2,031 in Massachusetts

#34,852 in US

Cambridge, MA, United States of America

Verve Therapeutics, Inc.